EMERGENT BIOSOLUTIONS INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
EMERGENT BIOSOLUTIONS INC. (EBS) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-27
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $300.00K, a 88.46% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $2.60M, a 271.43% increase from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $700.00K, a 86.27% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $5.10M.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $2.60M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $700.00K 10-K · filed 2026-02-27 | |
| 2022-12-31 | $5.10M 10-K · filed 2025-03-04 | $8.00M 10-K · filed 2023-03-01 |
| 2021-12-31 | $0.00 10-K · filed 2024-03-08 | |
| 2020-12-31 | $0.00 10-K/A · filed 2023-12-11 | |
| 2019-12-31 | $0.00 10-K · filed 2020-02-25 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | |
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 | |
| 2015-12-31 | $0.00 10-K · filed 2018-02-23 | |
| 2014-12-31 | $125.00K 10-K · filed 2017-02-28 | -$125.00K 10-K · filed 2015-03-09 |
| 2013-12-31 | -$75.00K 10-K · filed 2016-02-29 | |
| 2012-12-31 | $0.00 10-K · filed 2015-03-09 | |
| 2011-12-31 | $0.00 10-K · filed 2014-03-10 | |
| 2010-12-31 | $0.00 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |